COVID-19 antiviral treatments: Guidelines and resources

SA Health Clinical Guidelines

Treatment Recommendations for Hospitalised Adult Patients

The Treatment Recommendations for Hospitalised Adult Patients clinical guideline has been developed by the Central Adelaide Local Health Network Antimicrobial Stewardship Committee and endorsed for use statewide in SA Health by the COVID-19 Medicines Advisory Group. For the latest updates to PBS eligibility, please check the PBS website.

Medication Management of Mild Illness in the Outpatient Setting

The following COVID-19 Mild Illness treatment guidelines have been developed by the Central Adelaide Local Health Network Antimicrobial Stewardship Committee and initially endorsed for SA Health use by the South Australia Medicines Advisory Committee on 19 January 2022, the guidelines have been updated to reflect changes in clinical evidence, national and international guidelines, and patient access pathways such as updates to the Pharmaceutical Benefits Scheme (PBS).  For the latest updates to PBS eligibility, please check the PBS website.

Prescriber information sheets

Drug monographs

Australian guidelines and recommendations

Medication recommendations for COVID-19 can change rapidly due to demand and supply constraints, ongoing research and as novel agents are discovered. For the most up to date Australian guidelines and recommendations refer to:

Patient education resources

molnupiravir (Lagevrio®)

nirmatrelvir plus ritonavir (Paxlovid®)

remdesivir (Veklury®)